Related Experiment Video
Updated: Dec 3, 2025

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
[Polymyalgia rheumatic and chronic myelomonocytic leukemia]
A Delapierre1, C Nganoa2, E Maitre3
1Service de rhumatologie, CHU de Caen, avenue de la Côte de Nacre, 14033 Caen cedex 9, France.
This case report highlights a patient with chronic myelomonocytic leukemia (CMML) who developed polymyalgia rheumatica and pericarditis. Early screening for myelodysplasia is crucial in elderly patients with unexplained systemic symptoms and abnormal blood counts.
Area of Science:
- Hematology
- Rheumatology
- Internal Medicine
Background:
- Myelodysplastic syndromes (MDS) can present with systemic symptoms, including rheumatological conditions like connective tissue diseases and vasculitis.
- Rheumatological manifestations are recognized complications within the context of myelodysplastic syndromes.
- This report details a patient with chronic myelomonocytic leukemia (CMML) experiencing systemic symptoms of polymyalgia rheumatica and pericarditis.
Observation:
- A 78-year-old patient with a three-year history of CMML presented with inflammatory shoulder pain and systemic symptoms.
- The patient exhibited biological inflammatory syndrome, asthenia, anorexia, and significant weight loss.
- Diagnostic workup confirmed polymyalgia rheumatica and a pericardial effusion requiring urgent drainage.
Findings:
- The patient's symptoms of polymyalgia rheumatica and pericarditis emerged during a period of worsening hematological status in his CMML.
- Rheumatological symptoms resolved favorably with short-term corticosteroid treatment.
- The pericarditis did not recur during a two-year follow-up period.
Implications:
- Screening for myelodysplastic syndromes (MDS) is recommended for patients presenting with systemic manifestations, particularly in elderly individuals with cytopenia, macrocytosis, or monocytosis.
- This case underscores the importance of considering hematological disorders in the differential diagnosis of unexplained rheumatological and systemic inflammatory conditions.
- Timely diagnosis and management of MDS-associated systemic symptoms can lead to favorable patient outcomes.
More Related Videos
08:00A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
Published on: October 14, 2016
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
Related Concept Videos
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies